• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Oncology Med Announces a 14% Revenue Increase for Fiscal Year 2007 From the Prior Year

Posted on: Monday, 10 March 2008, 12:00 CDT

Oncology Med, Inc. (PINKSHEETS: ONCO) announced its unaudited results for the fiscal year 2007 shows a 14% increase in revenues to $ 1,745,606.00 from $ 1,536,100.00 for the fiscal year ended 2006. The Company had a net loss of only ($ 76,572.00) for the fiscal year ended 2007 as compared to a net loss of ($ 213,310.00) for fiscal year 2006.

Dr. William J. Walker, chairman of Oncology Med, Inc., stated, "I am extremely pleased with our results for 2007. We have achieved a substantial increase in revenue for fiscal year 2007 over the same period last year. We will have revenues in excess of $ 2,000,000.00 for fiscal year 2008 in addition to achieving net income for the period."

About Oncology Med, Inc.

Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation plans to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.

More information about Oncology Med, Inc. can be found at www.oncologymed.com.

NOTE: This press release may contain "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may,""will,""should,""could,""expects,""plans,""intends,""anticipates,""believes,""estimates,""predicts,""potential,""continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results.

 For information, please contact:  Email Contact

SOURCE: Oncology Med

Source: MARKET WIRE

More News in this Category